Liver Transplantation

Article	Citations
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic	499
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis	66
Racial, Gender, and Socioeconomic Disparities in Liver Transplantation	57
The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction	57
Sequential Use of Normothermic Regional and Ex Situ Machine Perfusion in Donation After Circulatory Death Liver Transplant	51
Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients	50
Physical Function, Physical Activity, and Quality of Life After Liver Transplantation	50
Robotic Versus Open Right Lobe Donor Hepatectomy for Adult Living Donor Liver Transplantation: A Propensity Score–Matched Analysis	46
Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute‐on‐Chronic Liver Failure	46
Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction?	45
A Review of the Current State of Liver Transplantation Disparities	42
Hypothermic Oxygenated Perfusion Improves Extended Criteria Donor Liver Graft Function and Reduces Duration of Hospitalization Without Extra Cost: The PERPHO Study	38
Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria	36
Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation	35
Assessment and Transplantation of Orphan Donor Livers: A Back‐to‐Base Approach to Normothermic Machine Perfusion	34
Safety and Benefit of Transesophageal Echocardiography in Liver Transplant Surgery: A Position Paper From the Society for the Advancement of Transplant Anesthesia (SATA)	34
Introducing EL‐FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates	33
The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver Transplantation	32
Sarcopenia in Children With End‐Stage Liver Disease on the Transplant Waiting List	32
Using Artificial Intelligence for Predicting Survival of Individual Grafts in Liver Transplantation: A Systematic Review	32
Liver Transplantation From Controlled Donors After Circulatory Death Using Normothermic Regional Perfusion: An Initial French Experience	32
Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center‐Level Variability	31
Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients	31
Liver Transplantation for Acute Intermittent Porphyria	31
Bile Composition as a Diagnostic and Prognostic Tool in Liver Transplantation	30

The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End‐Stage Liver Disease Scores and Exception Statuses	30
A 6‐Month Report on the Impact of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Acuity Circles Policy Change	29
The Emerging Role of Viability Testing During Liver Machine Perfusion	28
Low Health Literacy Is Associated With Frailty and Reduced Likelihood of Liver Transplant Listing: A Prospective Cohort Study	28
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes	27
The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach	27
Pure Laparoscopic Donor Hepatectomy: A Multicenter Experience	25
The New Horizon of Split‐Liver Transplantation: Ex Situ Liver Splitting During Hypothermic Oxygenated Machine Perfusion	25
Higher Mortality in Pediatric Liver Transplant Candidates With Sarcopenia	25
Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry	24
Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine‐Based and Cystatin C–Based Equations: Systematic Review and Meta‐Analysis	24
The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin	24
Donor‐Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes	24
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	24
Preliminary Analysis of the Impact of the Coronavirus Disease 2019 Outbreak on Italian Liver Transplant Programs	24
Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort	23
The Microbiome and Hepatocellular Carcinoma	23
Clinical Factors Associated With Lack of Serological Response to SARS‐CoV‐2 Messenger RNA Vaccine in Liver Transplantation Recipients	23
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors	23
Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis	22
Role of Molecular Biomarkers in Liver Transplantation for Hepatocellular Carcinoma	22
Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case‐Matched Single‐Cente	22
In‐Person Outreach and Telemedicine in Liver and Intestinal Transplant: A Survey of National Practices, Impact of Coronavirus Disease 2019, and Areas of Opportunity	22
Post–Liver Transplant Acute Kidney Injury	22
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy	21
Differential Impact of Extended Criteria Donors After Brain Death or Circulatory Death in Adult Liver Transplantation	21
Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry	21
Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States	21
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver‐Kidney Utilization and Outcomes	20
Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak on Pediatric Liver Transplant Recipients in Lombardy, Northern Italy	20
Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re‐Evaluating Age Limits in Transplantation Consortium	20
A review of racial, socioeconomic, and geographic disparities in pediatric liver transplantation	20
In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death	20
The Predictive Role of Model for End‐Stage Liver Disease–Lactate and Lactate Clearance for In‐Hospital Mortality Among a National Cirrhosis Cohort	20
Use of Artificial Intelligence as an Innovative Method for Liver Graft Macrosteatosis Assessment	20
Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions	20
Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes	20
The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention‐to‐Treat Analysis	19
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome	19
Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute‐on‐Chronic Liver Failure	18
Guillain‐Barré Syndrome After COVID‐19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response	18
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis	18
Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of Care	18
Regulatory T Cell Therapy Following Liver Transplantation	18
Liver Transplant Survivorship	18
Steroid‐Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination	18
Donor Morbidity Is Equivalent Between Right and Left Hepatectomy for Living Liver Donation: A Meta‐Analysis	17
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	17
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study	17
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest‐Risk Hepatocellular Carcinoma Patients	17

Use of Skeletal Muscle Index as a Predictor of Wait‐List Mortality in Patients With End‐Stage Liver Disease	17
Outcomes of Coronavirus Disease 2019 in Living Donor Liver Transplant Recipients	17
Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension	17
Liver transplantation of partial grafts after ex situ splitting during hypothermic oxygenated perfusion—The HOPE–Split pilot study	17
Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver Transplantation	16
External Validation of the VOCAL‐Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems	16
Extracellular Vesicles as a Novel Therapeutic Option in Liver Transplantation	16
Location and allocation: Inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe	16
Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation: A Meta‐Analysis	16
Association of Perfusion Characteristics and Posttransplant Liver Function in Ischemia‐Free Liver Transplantation	16
Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis	16
Financial burden in adults with chronic liver disease: A scoping review	16
Use of Hepatitis C Nucleic Acid Test–Positive Liver Allografts in Hepatitis C Virus Seronegative Recipients	16
Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis	16
Identifying Modifiable Predictors of Long‐Term Survival in Liver Transplant Recipients With Diabetes Mellitus Using Machine Learning	16
Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants	16
Pretransplant Intensive Care Unit Management and Selection of Grade 3 Acute‐on‐Chronic Liver Failure Transplant Candidates	16
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution	15
Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States	15
Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial	15
Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States	15
Technical Choices in Pediatric Living Donor Liver Transplantation: The Path to Reduce Vascular Complications and Improve Survival	15
Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time	15
Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium	15
Bile Biochemistry Following Liver Reperfusion in the Recipient and Its Association With Cholangiopathy	15
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta‐Analysis	15
A New Approach for Increasing Availability of Liver Grafts and Donor Safety in Living Donor Liver Transplantation: LD‐RAPID Procedure in the Cirrhotic Setting With Hepatocellular Carcinoma	15
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	15
Cardiac Risk Stratification in Liver Transplantation: Results of a Tiered Assessment Protocol Based on Traditional Cardiovascular Risk Factors	14
Medicaid Expansion Association With End‐Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage	14
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	14
Propensity Score–Matched Analysis of Posttransplant Outcomes in Living Donor Liver Transplantation for Older Adult Recipients	14
Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes	14
Coronary Computed Tomography Angiography Demonstrates a High Burden of Coronary Artery Disease Despite Low‐Risk Nuclear Studies in Pre–Liver Transplant Evaluation	14
Renal Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US Multicenter Simultaneous Liver‐Kidney Transplantation Consortium	14
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy?	14
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers	14
A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients	14
Minimally Invasive Living Donor Liver Transplantation: Pure Laparoscopic Explant Hepatectomy and Graft Implantation Using Upper Midline Incision	14
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria	14
Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver‐Kidney Allocation Policy	14
Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States	13
Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute‐on‐Chronic Liver Failure	13
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study	13
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours	13
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	13
Family Planning in Liver Transplant: Patient and Provider Knowledge and Practices	13
Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort	13
National Trends in Location of Death in Patients With End‐Stage Liver Disease	13
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study	13
Laparoscopic Living Donor Right Hepatectomy Regarding the Anatomical Variation of the Portal Vein: A Propensity Score–Matched Analysis	13
Genomics and Liver Transplantation: Genomic Biomarkers for the Diagnosis of Acute Cellular Rejection	12
Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation	12
Histidine‐Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis	12
Successful Pregnancy in a Liver Transplant Recipient on Belatacept	12
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <30	12
Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma	12
Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis	12
Role of Novel Kidney Biomarkers in Patients With Cirrhosis and After Liver Transplantation	12
Intraoperative risk factors of acute kidney injury after liver transplantation	12
Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis	12
Definition and Prospective Assessment of Functional Recovery After Liver Transplantation: A New Objective Consensus‐Based Metric for Safe Discharge	12
Superior Long‐Term Outcomes of Adult Living Donor Liver Transplantation: A Cumulative Single‐Center Cohort Study With 20 Years of Follow‐Up	12
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	12
Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis	12
Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis	12
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient	12
What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model	12
Hypothermic oxygenated machine perfusion as a tool to facilitate liver transplantation in the acute‐on‐chronic liver failure scenario	11
Early Predictors of Short‐Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis	11
Renal Dysfunction After Liver Transplantation: Effect of Donor Type	11
Comparison of Wait‐List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates	11
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic	11
Clinical Significance of Spontaneous Portosystemic Shunts in Living Donor Liver Transplantation	11
Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective	11
The Impact of Median Model for End‐Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma	11
Complete transition from open surgery to laparoscopy: 8‐year experience with more than 500 laparoscopic living donor hepatectomies	11
Drug‐Induced Liver Injury After Liver Transplantation	11
Risk Factors and Center‐Level Variation in Hepatocellular Carcinoma Under‐Staging for Liver Transplantation	11
Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival	11

Recurrence After Curative Resection of Hepatitis B Virus–Related Hepatocellular Carcinoma: Diagnostic Algorithms on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging	11
Cannabinoid Use Among Liver Transplant Recipients	11
The Current Landscape of Liver Transplantation After Ex Situ Machine Perfusion and Normothermic Regional Perfusion in the United States	11
What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App	11
Survival Benefit of Split‐Liver Transplantation for Pediatric and Adult Candidates	11
The Future of Quality Improvement for Cirrhosis	11
Center use of technical variant grafts varies widely and impacts pediatric liver transplant waitlist and recipient outcomes in the United States	10
Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation	10
Can Living Donor Liver Transplantation in the United States Reach Its Potential?	10
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	10
Utility of Preoperative Computed Tomography–Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients	10
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry	10
Interleukin‐10 and Transforming Growth Factor‐β Cytokines Decrease Immune Activation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver	10
Long‐Term Safety and Efficacy of Pure Laparoscopic Donor Hepatectomy in Pediatric Living Donor Liver Transplantation	10
Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma	10
Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access	10
Combined Lung and Liver Transplantation for Short Telomere Syndrome	10
Center Variation in Intention‐to‐Treat Survival Among Patients Listed for Liver Transplant	10
Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center‐Level Variability	10
Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements	10
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment	10
Use of Dual Hypothermic Oxygenated Machine Perfusion to Recover Extended Criteria Pediatric Liver Grafts	10
Is Blood Transfusion a Means of False Positive Phosphatidylethanol Testing?	10
Donation after circulatory death transplant outcomes using livers recovered by local surgeons	10
Efficacy and Safety of Endoscopic Balloon Placement for Weight Loss in Patients With Cirrhosis Awaiting Liver Transplantation	10
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: A systematic review	10
Portal Vein Complications After Adult Living Donor Liver Transplantation: Time of Onset and Deformity Patterns Affect Long‐Term Outcomes	10
Opioid Avoidance in Liver Transplant Recipients: Reduction in Postoperative Opioid Use Through a Multidisciplinary Multimodal Approach	10
Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short‐Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change	10
Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation: A Pilot Study	9
Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies	9
Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation	9
Black Race Is Associated With Higher Rates of Early‐Onset End‐Stage Renal Disease and Increased Mortality Following Liver Transplantation	9
Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis	9
Planned Initiation of Venoarterial Extracorporeal Membrane Oxygenation Prior to Liver Transplantation in a Patient With Severe Portopulmonary Hypertension	9
Platelets Stimulate Liver Regeneration in a Rat Model of Partial Liver Transplantation	9
Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries	9
Liver Transplant Recipient, Caregiver, and Provider Perceptions of Cardiovascular Disease and Related Risk Factors After Transplant	9
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic	9
Caregiver perspectives on the everyday medical and social needs of long‐term pediatric liver transplant patients	9
Cardiac Risk Assessment in Liver Transplant Candidates: A Survey of National Practice Patterns	9
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma	9
MicroRNAs 155‐5p, 122‐5p, and 181a‐5p Identify Patients With Graft Dysfunction Due to T Cell–Mediated Rejection After Liver Transplantation	9
Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation	9
Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive Setting	8
Debate on Selection Criteria for Liver Transplantation for Alcoholic Hepatitis: Tighten or Loosen?	8
A Multicentric Experience on Living Donor Liver Transplantation in Coronavirus Disease 2019 Hotspots in India	8
Longterm Outcome of Liver Transplantation for Congenital Extrahepatic Portosystemic Shunt	8
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients	8
The 6‐Minute Walk Test Distance Predicts Mortality in Cirrhosis: A Cohort of 694 Patients Awaiting Liver Transplantation	8
Improvements in Disease‐Specific Health‐Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal	8
Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis	8
Portal vein complications and outcomes following pediatric liver transplantation: Data from the Society of Pediatric Liver Transplantation	8
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients	8
Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta‐Analysis	8
National experience with living donor liver transplantation for hepatocellular carcinoma	8
Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort	8
Malnutrition in Biliary Atresia: Assessment, Management, and Outcomes	8
New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia	8
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	8
Managing Recipient Hepatic Artery Intimal Dissection During Living Donor Liver Transplantation	8
Cadence From Physical Activity Trackers for Monitoring of Home‐Based Exercise Intensity in Advanced Liver Disease	8
Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care	8
Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation	8
Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation	8
Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies	8
Black patients and women have reduced access to liver transplantation for alcohol‐associated liver disease	8
Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease	8
Coronavirus Disease 2019 in the Early Postoperative Period of Liver Transplantation: Is the Outcome Really So Positive?	8
Demarcating the Exact Midplane of the Liver Using Indocyanine Green Near‐Infrared Fluorescence Imaging During Laparoscopic Donor Hepatectomy	8
Acute‐on‐Chronic Liver Failure and Liver Transplantation: Putting the Cart Before the Horse in Data Analyses and Advocating for Model for End‐Stage Liver Disease Exceptions	7
Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation	7
Microsteatosis in Livers From Donation After Circulatory Death Donors Is Associated With Inferior Outcomes Following Liver Transplantation	7
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States	7
Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post–Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study	7
What Role Should Acute‐on‐Chronic Liver Failure Play in Liver Transplant Prioritization? A Survey of US‐Based Transplant Providers	7
Molecular Mismatch Predicts T Cell–Mediated Rejection and De Novo Donor‐Specific Antibody Formation After Living Donor Liver Transplantation	7
Temporal Trends and Evolving Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US SLKT Consortium	7
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transpla	7
Direct‐Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait‐List Progression or Posttransplant Recurrence	7
Acute Graft‐Versus‐Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning	7
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation	7
Outcome of Extended Right Lobe Liver Transplantations	7
Utility of phosphatidylethanol testing in liver transplant evaluation: examining concordance to self-reported alcohol use	7
Biliary Reconstruction in Adult Living Donor Liver Transplantation: The All‐Knots‐Outside Technique	7
Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation	7
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	7
Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5‐Year Follow‐Up	7
Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects	7
Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America	7
Impact of Medial Reduction of the Left Lateral Segment: A Novel Technique for Living Donor Liver Transplantation for Small Pediatric Recipients	6
Prediction of long‐term morbidity and mortality after liver transplantation using two‐dimensional shear wave elastography compared with liver biopsy	6
Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss	6
Livers From Pediatric Donation After Circulatory Death Donors Represent a Viable and Underutilized Source of Allograft	6
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single‐Center Analysis	6